Abstract
The notion that protein-coding genes are the only biologically significant moieties in the genome is revolutionarized by the discovery of non-coding RNAs. Among them is a group of small non-coding RNAs termed microRNAs (miRNAs) that has recently been brought to the limelight. Their presence in the genome was only realized after the identification of their founders lin-4 and let-7 in C. elegans through genetic screens. To date, several hundreds of microRNAs have been identified. They are single-stranded RNA molecules of ∼21-22 nucleotides long, excised from precursors of ∼70 nucleotides predicted in silico to from imperfect stem-loop structures. Many of these miRNAs are evolutionarily conserved, implicating important biological functions. Emerging data points to an important role of these tiny RNA molecules in regulating gene expression of target RNAs by at least two post-transcriptional mechanisms: binding to imperfect complementary sequence of the 3 untranslated region (3UTR) and repressing translation; and endonucleolytic cleavage by a double-stranded RNA-mediated interference (RNAi) mechanism through base-pairing with perfect or near-perfect complementary sequence. Studies in several miRNAs in plants and animals illustrate that these small riboregulators can play critical roles in developmental timing and spatial control of cell fate decisions, cell proliferation, apoptosis, cell differentiation and cell metabolism. Developmental defects and tumorigenesis can be a consequence of abnormal expression of miRNAs. This review discusses the biological functions, mechanisms of action, biogenesis and regulation of miRNAs, as well as identification of their target genes, highlighting the potential diversity of this novel class of gene regulators.
Keywords: microrna, gene regulation, untranslated region, translation
Current Genomics
Title: MicroRNAs: Tiny but Not Trivial
Volume: 5 Issue: 3
Author(s): Wayne Tam
Affiliation:
Keywords: microrna, gene regulation, untranslated region, translation
Abstract: The notion that protein-coding genes are the only biologically significant moieties in the genome is revolutionarized by the discovery of non-coding RNAs. Among them is a group of small non-coding RNAs termed microRNAs (miRNAs) that has recently been brought to the limelight. Their presence in the genome was only realized after the identification of their founders lin-4 and let-7 in C. elegans through genetic screens. To date, several hundreds of microRNAs have been identified. They are single-stranded RNA molecules of ∼21-22 nucleotides long, excised from precursors of ∼70 nucleotides predicted in silico to from imperfect stem-loop structures. Many of these miRNAs are evolutionarily conserved, implicating important biological functions. Emerging data points to an important role of these tiny RNA molecules in regulating gene expression of target RNAs by at least two post-transcriptional mechanisms: binding to imperfect complementary sequence of the 3 untranslated region (3UTR) and repressing translation; and endonucleolytic cleavage by a double-stranded RNA-mediated interference (RNAi) mechanism through base-pairing with perfect or near-perfect complementary sequence. Studies in several miRNAs in plants and animals illustrate that these small riboregulators can play critical roles in developmental timing and spatial control of cell fate decisions, cell proliferation, apoptosis, cell differentiation and cell metabolism. Developmental defects and tumorigenesis can be a consequence of abnormal expression of miRNAs. This review discusses the biological functions, mechanisms of action, biogenesis and regulation of miRNAs, as well as identification of their target genes, highlighting the potential diversity of this novel class of gene regulators.
Export Options
About this article
Cite this article as:
Tam Wayne, MicroRNAs: Tiny but Not Trivial, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349435
DOI https://dx.doi.org/10.2174/1389202043349435 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents
Mini-Reviews in Medicinal Chemistry Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Adenocarcinoma of the Appendix in Elderly: Diagnostic Dilemma
New Emirates Medical Journal Bruton's Tyrosine Kinase Inhibition in the Treatment of Preclinical Models and Multiple Sclerosis
Current Pharmaceutical Design Response Surface Methodology for Optimization of Ultrasound Assisted Extraction of Swertiamarin from Enicostema littorale Blume
Current Bioactive Compounds The Relationship between Ferroptosis and Tumors: A Novel Landscape for Therapeutic Approach
Current Gene Therapy Targeting Histone Deacetylase Inhibitors for Anti-Malarial Therapy
Current Topics in Medicinal Chemistry Brain Structural Effects of Psychopharmacological Treatment in Bipolar Disorder
Current Neuropharmacology The IL-7/IL-7 Receptor Axis: Understanding its Central Role in T-Cell Homeostasis and the Challenges Facing its Utilization as a Novel Therapy
Current Drug Targets Monoclonal Antibodies in Clinical Oncology
Anti-Cancer Agents in Medicinal Chemistry Studying the Ethno-Pharmacological Basis of Antiepileptic Activity of Medhya Rasayanas- A Nootropic Package From Ayurveda
Current Traditional Medicine Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer
Current Cancer Drug Targets Coumarins as Antioxidants
Current Medicinal Chemistry The Risk of Progressive Multifocal Leukoencephalopathy Under Biological Agents Used in the Treatment of Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo
Current Drug Targets An Evolving Role of Piperazine Moieties in Drug Design and Discovery
Mini-Reviews in Medicinal Chemistry Neutrophil Extracellular Traps as a Drug Target to Counteract Chronic and Acute Inflammation
Current Pharmaceutical Biotechnology Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
Current Medicinal Chemistry Self-aggregated Nanoparticles of Cholesterol-modified Pullulan Conjugate as a Novel Carrier of Mitoxantronep
Current Nanoscience